Products/Services Used | Details | Operation |
---|---|---|
Catalog Antibody> | / METHOD DETAILS in vivo manipulations Experimental and control mice were immunized subcutaneously in the lateral abdomen with 200 mg MOG35–55 (Genscript) in CFA (BD), and 200 ng pertussis toxin (LuBio) in PBS was administered intraperitoneally on day 0 and day 2 as described previously (Co- darri et al....e1–e6, May 21, 2019 e5 MOG35-55 (20 mg/mL; Genscript) or anti-CD3 (2 mg/mL; 3C11; BioXCell) and anti-CD28 (2 mg/mL; 37. | Get A Quote |
Pathogenic lymphocytes initiate the development of chronic inflammatory diseases. The cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) (encoded by Csf2) is a key communicator between pathogenic lymphocytes and tissue-invading inflammatory phagocytes. However, the molecular properties of GM-CSF-producing cells and the mode of Csf2 regulation in vivo remain unclear. To systematically study and manipulate GM-CSF cells and their progeny in vivo, we generated a fate-map and reporter of GM-CSF expression mouse strain (FROG). We mapped the phenotypic and functional profile of auto-aggressive T helper (Th) cells during neuroinflammation and identified the signature and pathogenic memory of a di... More